Abstracts

Call for Abstracts

Regular Call Abstract Submission:
Site Opens – Wednesday, April 10, 2019
Site Closes – Wednesday, June 19, 2019

Short Call Abstract Submission: 
Site Opens – Wednesday, August 14, 2019
Site Closes – Wednesday, August 28, 2019

Abstract Presentations

We invite you to submit your new research for oral or poster presentation during the Regular Call Abstract submission period.

Short Call Abstracts are reserved for the presentation of the very latest, important thyroid-related research with high impact. Submission of a Short Call Abstract does not guarantee acceptance for presentation. (Please note that Case Reports are ineligible for consideration as Short Call Abstracts.)

Abstracts may be selected as a Poster Presentation or an Oral Presentation. Only 37 abstracts will be invited for Regular Call Oral Presentations and 10 will be invited for Short Call Oral Presentations.

Abstract Submission Policy and Responsibilities of the Author

The American Thyroid Association (ATA) requests submission of abstracts for consideration at ATA scientific meetings to feature new data presented as posters or oral presentations. The ATA goal is to provide the audience and the media with new data that are unpublished (in print or electronic) which are being publicly presented for the first time. Authors are asked to strictly comply with this requirement; data that are to become available to the public in the setting of a national or international meeting before their presentation at the ATA meeting are not eligible for presentation at the ATA meeting. Data may be submitted for publication before or after abstract submission to the ATA. However, data accepted for publication prior to the ATA meeting would REQUIRE the authors to request the publisher to embargo their publication (electronic and print) until 8:00 am local time the first day of the ATA meeting, or would REQUIRE the authors to withdraw their abstract from the ATA meeting. Many editors are favorable to embargo requests because of the attention that may be drawn to the publication after original presentation of the data at a major meeting. Further, the authors are welcome to announce the date and place of their anticipated publication if known. Authors that do not comply with this policy may be restricted from future abstract submissions for a term to be determined by the ATA Executive Committee. Arbitration, if needed, will occur via the ATA Board of Directors.

Additional Policies

  • Character Limit: There is a limit of 2,245 characters (approx. 300 words) for the text of your submission.
  • Authors of accepted posters are required to register and be present during the assigned poster sessions.
  • Scientific materials presented must not have been submitted for publication at the time of abstract submission or presented at a scientific meeting before the 89th Annual Meeting of the ATA. (local and regional meetings excluded).
  • All abstracts must be submitted via the ATA Abstract site
  • Authorship on multiple abstracts is permitted.
  • Case reports are ineligible for consideration as Short Call Abstracts

Clinical Thyroidology® Trainee Case Reports and Visual Abstracts

The Editorial Board of the ATA’s Journal, Clinical Thyroidology®, will be reviewing case report submitted by trainees for the 89th Annual Meeting and will invite 8-10 novel case reports to submit a paper to be published in Clinical Thyroidology with an accompanying Visual Abstract. Select case reports will be scheduled for publication in 2020. If you are a trainee and interested in having your abstract considered for the Clinical Thyroidology Trainee Case Reports and Visual Abstracts program please indicate your interest when submitting a Regular Call abstract for the 89th Annual Meeting of the ATA. Also add the name and email of your Program Director/Mentor/Senior Author that would be willing to review your case report and visual abstract. The cost of publication for invited papers will be waived.